Results for: pharmaceutical+industry

Medical charity warns India over patent rules

Teva’s Sell Rating From Berenberg Bucks Bullish View on Copaxone

Pfizer’s Hunt Said to Have Included Rebuffed Teva Approach

Klarman’s Baupost Said to Beat Peers With Gains of as Much as 8%

Pfizer $33 Billion Question Remains After Teva, Actavis Feelers

Overseer: FIFA presidential 'candidates' not official yet

No more results returned for this search